20.06
Schlusskurs vom Vortag:
$19.59
Offen:
$19.61
24-Stunden-Volumen:
192.12K
Relative Volume:
0.98
Marktkapitalisierung:
$358.52M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-143.29
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
+6.14%
1M Leistung:
+5.97%
6M Leistung:
-8.02%
1J Leistung:
+98.42%
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Firmenname
Rigel Pharmaceuticals
Sektor
Branche
Telefon
650-624-1100
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RIGL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RIGL
Rigel Pharmaceuticals
|
20.06 | 337.79M | 116.88M | -25.09M | -20.74M | -0.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-04-03 | Fortgesetzt | Piper Sandler | Neutral |
2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
2022-06-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2022-06-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-03-23 | Eingeleitet | B. Riley Securities | Neutral |
2020-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-11-15 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2019-09-26 | Fortgesetzt | JP Morgan | Overweight |
2019-03-01 | Bestätigt | Cantor Fitzgerald | Overweight |
2018-08-27 | Eingeleitet | Citigroup | Buy |
2018-05-02 | Bestätigt | Cantor Fitzgerald | Overweight |
2017-12-21 | Fortgesetzt | Piper Jaffray | Overweight |
2017-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
2017-11-06 | Fortgesetzt | H.C. Wainwright | Buy |
2017-03-09 | Bestätigt | H.C. Wainwright | Buy |
2016-08-31 | Bestätigt | H.C. Wainwright | Buy |
2016-08-30 | Bestätigt | Piper Jaffray | Overweight |
2016-07-13 | Eingeleitet | H.C. Wainwright | Buy |
2016-06-13 | Eingeleitet | Piper Jaffray | Overweight |
2016-04-22 | Hochstufung | JP Morgan | Neutral → Overweight |
2013-04-08 | Bestätigt | Stifel | Buy |
2012-11-29 | Eingeleitet | UBS | Neutral |
2012-11-06 | Bestätigt | Oppenheimer | Outperform |
2012-03-26 | Eingeleitet | Canaccord Genuity | Hold |
2010-12-10 | Herabstufung | MP Advisors | Outperform → Market Perform |
Alle ansehen
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
What analysts say about Rigel Pharmaceuticals Inc. stockHigh-impact stock picks - jammulinksnews.com
Is Rigel Pharmaceuticals Inc. a good long term investmentOutstanding yields - jammulinksnews.com
(RIGL) Proactive Strategies - news.stocktradersdaily.com
Rigel Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com
What drives Rigel Pharmaceuticals Inc. stock priceTriple-digit returns - jammulinksnews.com
What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com
Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey
(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | RIGL Stock News - GuruFocus
Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛
Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada
Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com
High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com
Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World
Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria
Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com
Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq
Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider
Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow
Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise
Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus
Rigel to Present at the Jefferies Global Healthcare Conference – Company Announcement - Financial Times
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire
Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):